US 11,618,750 · Application 16/899,823 · Granted Apr 4, 2023
US 11,618,750
Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators
Estimated expiration
July 8, 2040
13y 305d remaining
Earliest effective filing
Jun 12, 2020
+ 20 years
Jun 12, 2040
PTA +26d
Jul 8, 2040
No TD
—
Final
Jul 8, 2040
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- June 12, 2020
- Earliest effective filing
- June 12, 2020
- Issue date
- April 4, 2023
- PTA
- +26 days
- Base expiry (before PTA)
- June 12, 2040
June 12, 2020 + 20 years = June 12, 2040 + 26 PTA days = July 8, 2040
- PRO62/861,656 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/899,823 · US 11,618,750
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,618,750: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11618750Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.